Document:

Exhibit 10.2

                            STOCK PURCHASE AGREEMENT

STOCK PURCHASE AGREEMENT, dated as of September 13, 2004 (this "Agreement"), by
and among Phyllis Maxwell, an individual having an address at Suite 1807-1501
Broadway, New York, NY 10036 ("Seller"), on the one hand, and First Jemini Trust
and/or its designees having an office and address at 76 Sanibel Crescent,
Thornhill, Ontario, Canada L4J 8K7 ("Purchaser"), on the other hand, and
Clixtix, Inc., a corporation incorporated under the laws of New York, having an
office and address at Suite 1807-1501 Broadway, New York, NY 10036 (the
"Company").

                               W I T N E S S E T H

            WHEREAS, Seller desires to sell to Purchaser 5,086,600 shares (the
"Shares") of the Company's common stock, par value $0.0001 per share (the
"Common Stock"), representing 49.7% of the Company's issued and outstanding
shares of the Common Stock of the Company, on the terms and conditions set forth
in this Stock Purchase Agreement ("Agreement");

            WHEREAS, Purchaser desires to buy the Shares on the terms and
conditions set forth herein;

            WHEREAS, the Company joins in the execution of this Agreement for
the purpose of evidencing its consent to the consummation of the foregoing
transactions and for the purpose of making certain representations and
warranties to, and covenants and agreements with, the Purchaser; and

            WHEREAS, in connection the purchase of the Shares, Phyllis Maxwell,
or her assignee, will purchase certain assets of the Company pursuant to that
certain Asset Purchase Agreement, between Phyllis Maxwell and the Company of
even date herewith, and the Company will acquire all of the outstanding capital
stock of Medeorex, Inc., pursuant to that certain Share Exchange Agreement
between the shareholders of Medeorex, Inc. and the Company of even date herewith
(the "Related Transactions").

            NOW, THEREFORE, in consideration of the promises and respective
mutual agreements herein contained, it is agreed by and between the parties
hereto as follows.

                                    ARTICLE 1
                         SALE AND PURCHASE OF THE SHARES

            1.1 Sale of the Shares. On the Closing Date (as hereinafter
defined), subject to the terms and conditions herein set forth, on the basis of
the representations, warranties and agreements herein contained, Seller shall
sell, assign, transfer and deliver all right, title and interest in and to the
Shares to the Purchaser free and clear of all liens, security interests,
pledges, encumbrances, charges, restrictions, demands and claims, of any kind or
nature whatsoever, whether direct or indirect or contingent to Purchaser who
shall purchase the Shares from the Seller.

<PAGE>

            1.2 The Closing. The purchase of the Shares shall be deemed
effective upon the consummation of the deliveries set forth in Sections 6.1(a)
and (b) and the Related Transactions (the "Closing"), and shall take place at
the office of Sierchio Greco & Greco, LLP, 720 Fifth Avenue, New York, New York
10019 or such other place as Purchaser and Seller may mutually agree, on
September 13, 2004. Such date is herein referred to as the "Closing Date."

            1.3 Instruments of Conveyance and Transfer. At the Closing, Seller
shall deliver to the Purchaser certificates representing the Shares, with
appropriate stock powers with medallion guarantees ("Certificates") as shall be
effective to vest in Purchaser all right, title and interest in and to all of
the Shares.

            1.4 Consideration and Payment for the Shares. In consideration for
the Shares, Purchaser shall pay to the Seller a total purchase price of Two
Hundred Forty-Eight Thousand, Two Hundred Forty-Five Dollars ($248,245) in cash
("Purchase Price"). Purchaser shall pay to the Seller the Purchase Price at the
Closing Date.

                                    ARTICLE 2
                  REPRESENTATIONS AND WARRANTIES OF THE SELLER

The Seller represents, warrants and undertakes to the Purchaser the following:

            2.1   Authority and Title.

                  (a)   Due Execution. This Agreement has been duly executed and
                        delivered by the Seller.

                  (b)   Valid Agreement. This Agreement constitutes, and upon
                        execution and delivery thereof by the Seller, will
                        constitute, a valid and binding agreement of the Seller
                        enforceable against the Seller in accordance with its
                        terms.

                  (c)   Authorization. No consent or authorization of the
                        Company, its Board of Directors, or its stockholders is
                        required for the execution, delivery or performance of
                        this Agreement.

                  (d)   Seller's Title to Shares; No Liens or Preemptive Rights;
                        Valid Issuance. Seller has and at the Closing will have
                        good and valid title and control of the Shares free and
                        clear of all encumbrances of any kind, except those
                        created in favor of the Purchaser pursuant hereto and
                        those created by applicable federal and state securities
                        laws; and on delivery to the Purchaser of the Shares,
                        good and valid title to all the Shares will pass to
                        Purchaser. The Shares have been legally and validly
                        issued in compliance with all applicable U.S. federal
                        and state securities laws, and are fully paid and
                        non-assessable shares of the Company's Common Stock; and
                        the Shares have all been issued under duly authorized
                        resolutions of the Board of Directors of the Company.

                                       2
<PAGE>

            2.2 No Governmental Action Required. The execution and delivery by
the Seller of this Agreement does not and will not, and the consummation of the
transactions contemplated hereby will not, require any action by or in respect
of, or filing with, any governmental body, agency or governmental official,
except for filings required to be made with the Securities and Exchange
Commission ("Commission") and the National Association of Securities Dealers
("NASD"), and except for such actions or filings that have been undertaken or
made prior to the date hereof and that will be in full force and effect (or as
to which all applicable waiting periods have expired) on and as of the date
hereof.

            2.3 Compliance with Applicable Law and Corporate Documents. The
execution and delivery by the Seller and the Company of this Agreement does not
and will not, and the sale by the Seller of the Shares and the consummation of
the other transactions contemplated by this Agreement does not and will not
contravene or constitute a default under or violation of (or constitute an event
which might, upon passage of time or giving of notice, constitute a default
under or violation of) (i) any provision of applicable law or regulation, (ii)
the articles of incorporation or by-laws or any other governing document of the
Company or (iii) any agreement, judgment, injunction, order, decree or other
instrument binding upon the Seller or any of her or the Company's assets, or
result in the creation or imposition of any lien on any asset of the Seller.

            2.4 Due Diligence Materials. The information heretofore furnished by
the Seller to the Purchaser for purposes of or in connection with this Agreement
or any transaction contemplated hereby does not, and all such information
hereafter furnished by the Seller to the Purchaser will not (in each case taken
together and on the date as of which such information is furnished), contain any
untrue statement of a material fact or omit to state a material fact necessary
in order to make the statements contained therein, in the light of the
circumstances under which they are made, not misleading.

            2.5 Not a Voting Trust: No Proxies. None of the Shares are or will
be subject to any voting trust or agreement. No person holds or has the right to
receive any proxy or similar instrument with respect to the Shares. Except as
provided in this Agreement, the Seller is not a party to any agreement which
offers or grants to any person the right to purchase or acquire any of the
Shares. There is no applicable local, state or federal law, rule, regulation, or
decree which would, as a result of the sale contemplated by this Agreement,
impair, restrict or delay any voting rights with respect to the Shares.

            2.6 Survival of Representations. The representations and warranties
made herein by the Seller will be true and correct in all material respects on
and as of the Closing Date with the same force and effect as though said
representations and warranties had been made on and as of the Closing and will,
except as provided herein, survive the Closing Date until the earlier of the
expiration of the applicable statute of limitations or the date that is six
years from the Closing Date.

            2.7 Adoption of Company's Representations. The Seller adopts and
remakes as her own each and every representation, warranty and undertaking made
by the Company in Article 3 below as if she had made such representations,
warranties and undertakings to the Purchaser directly.

                                       3
<PAGE>

            2.8 No Solicitation. No form of solicitation was used by the Seller
or, to the best of her actual knowledge, any other person acting on behalf of
the Seller, in connection with the offer and sale of the Shares. Neither the
Seller, nor, to her knowledge, any person acting on behalf of the Seller, has,
either directly or indirectly, sold or offered for sale to any person (other
than the Purchaser) any of the Shares, and the Seller represents that she will
not, nor will any person authorized to act on her behalf (except that the Seller
makes no representation as to the Purchaser) sell or offer for sale any such
security to, or solicit any offers to buy any such security from, or otherwise
approach or negotiate in respect thereof with, any person or persons so as
thereby to cause the issuance or sale of any of the Shares to be in violation of
any of the provisions of Section 5 of the Securities Act of 1933 or any other
provision of law.

            2.9 Brokers. Except for commissions payable by Purchaser to Dwain
Brannon, no broker, finder or investment banker is entitled to any brokerage,
finder's or other fee or commission payable by the Purchaser or the Company in
connection with the transactions contemplated by this Agreement.

                                    ARTICLE 3
           REPRESENTATIONS AND WARRANTIES WITH RESPECT TO THE COMPANY

The Company represents, warrants and undertakes to the Purchaser the following:

            3.1 Due Organization. Except for Maxwell Group Entertainment, Inc.,
the Company has no subsidiaries. Each of the Company and its subsidiary is a
corporation duly organized, validly existing and in good standing under the laws
of the State of New York (a) with full power and authority to own, lease, use,
and operate its properties and to carry on its business as and where now owned,
leased, used, operated and conducted. Neither the Company nor its subsidiary is
qualified to conduct business in any jurisdiction other than the State of New
York and (b) all actions taken by the current directors and stockholders of the
Company have been valid and in accordance with the laws of the State of New York
and all actions taken by the Company have been duly authorized by the current
directors and stockholders of the Company as appropriate.

            3.2   (a)   Company Authority. The Company has all requisite
corporate power and authority to enter into and perform this Agreement and to
consummate the transactions contemplated herein.

                  (b)   Due Authorization. The execution, delivery and
                        performance by the Company of this Agreement has been
                        duly and validly authorized and no further consent or
                        authorization of the Company, its Board of Directors or
                        its stockholders is required. The Seller is not
                        disqualified from acting as a director with respect to
                        the transactions contemplated hereby by reason of her
                        interest in the transactions.

                  (c)   Valid Execution. This Agreement has been duly executed
                        and delivered by the Company.

                                       4
<PAGE>

                  (d)   Binding Agreement. This Agreement constitutes, and upon
                        execution and delivery thereof by the Company, will
                        constitute, a valid and binding agreement of the
                        Company, enforceable against the Company in accordance
                        with its terms.

                  (e)   No Violation of Corporate Documents or Agreements. The
                        execution and delivery of this Agreement by the Company
                        and the performance by the parties hereto of their
                        obligations hereunder will not cause, constitute, or
                        conflict with or result in (i) any breach or violation,
                        or give rise to a right of termination, cancellation or
                        acceleration of any obligation or to loss of a material
                        benefit under, or to increased, additional, accelerated
                        or guaranteed rights or entitlements of any person under
                        any of the provisions of, or constitute a default under,
                        any license, indenture, mortgage, charter, instrument,
                        articles of incorporation, bylaw, judgment, order,
                        decision, writ, injunction, or decree or other governing
                        document, agreement or instrument or proceeding to which
                        the Company or its stockholders are a party, or by which
                        they may be bound, nor will any consents or
                        authorizations of any party other than those hereto by
                        required, (ii) an event that (including an event that
                        with the passage of time or the giving of notice) would
                        cause the Company to be liable to any party, or (iii) an
                        event that (including an event that with the passage of
                        time or the giving of notice) would result in the
                        creation or imposition of any lien, charge or
                        encumbrance on any asset of the Company or on the
                        securities of the Company to be acquired by the
                        Purchaser.

            3.3 Authorized Capital, No Preemptive Rights, No Liens;
Anti-Dilution. As of the date hereof, the authorized capital of the Company is
20,000,000 shares of Common Stock, with a par value of $0.0001 per share. There
is no authorized preferred stock of any kind. The issued and outstanding capital
stock of the Company is 10,228,000 shares of Common Stock. All of the shares of
capital stock are duly authorized, validly issued, fully paid and
non-assessable. No shares of capital stock of the Company are subject to
preemptive rights or similar rights of the stockholders of the Company or any
liens or encumbrances imposed through the actions or failure to act of the
Company, or otherwise. As of the date hereof (i) there are no outstanding
options, warrants, convertible securities, scrip, rights to subscribe for, puts,
calls, rights of first refusal, tag-along agreements, nor any other agreements,
understandings, claims or other commitments or rights of any character
whatsoever relating to, or securities or rights convertible into or exchangeable
for any shares of capital stock of the Company, or arrangements by which the
Company is or may become bound to issue additional shares of capital stock of
the Company, and (ii) there are no agreements or arrangements under which the
Company is obligated to register the sale of any of its securities under the
Securities Act and (iii) there are no anti-dilution or price adjustment
provisions contained in any security issued by the Company (or in the Company's
articles of incorporation or by-laws or in any agreement providing rights to
security holders) that will be triggered by the transactions contemplated by
this Agreement. The Company has furnished to Purchaser true and correct copies
of the Company's articles of incorporation and by-laws, copies of which are
attached to this Agreement at Exhibit 1.

                                       5
<PAGE>

            3.4 No Governmental Action Required. The execution and delivery by
the Seller of this Agreement does not and will not, and the consummation of the
transactions contemplated hereby will not, require any action by or in respect
of, or filing with, any governmental body, agency or governmental official,
except for filings required to be made with the Commission and the NASD, and
except for such actions or filings that have been undertaken or made prior to
the date hereof and that will be in full force and effect (or as to which all
applicable waiting periods have expired) on and as of the date hereof.

            3.5 Compliance with Applicable Law and Corporate Documents. The
execution and delivery by the Company of this Agreement and the performance by
the parties hereto of the transactions contemplated hereby does not and will not
contravene or constitute a default under or violation of (or constitute an event
which might upon the passage of time or the giving of notice could result in
default or a violation of) (i) any provision of applicable law or regulation,
(ii) the Company's articles of incorporation or bylaws or any other governing
document, or (iii) any agreement, judgment, injunction, order, decree or other
instrument binding upon the Company or any of its assets, or result in the
creation or imposition of any lien on any asset of the Company. The Company is
in compliance with and conforms to all statutes, laws, ordinances, rules,
regulations, orders, restrictions and all other legal requirements of any
domestic or foreign government or any instrumentality thereof having
jurisdiction over the conduct of its businesses or the ownership of its
properties.

            3.6 SEC Representations. Through the date hereof, the Company has
duly, timely, accurately and completely filed all forms, reports and documents
with the Commission required to be filed by it pursuant to Section 15(d) of the
Securities Exchange Act of 1934 including without limitation its registration
statement on Form SB-2 ("SEC Reports"). The Company has fewer than 500
shareholders of record as determined in accordance with Rule 12g5-1 and is not
required to register its shares under the Securities Exchange Act of 1934. True
and complete copies of the required SEC Reports have been made available to the
Purchaser by the Seller and are incorporated herein by reference. Such SEC
Reports, at the time filed, complied in all material respects with the
requirements of the federal and state securities laws and the rules and
regulations of the Commission thereunder applicable to such SEC Reports. Except
as set forth on Schedule 3.6 hereto, none of the SEC Reports, including without
limitation, any financial statements or schedules included therein, contains any
untrue statement of a material fact or omits to state a material fact necessary
in order to make the statements made, in light of the circumstances under which
they were made, not misleading.

            3.7 Financial Statements.

                  (a)   The Purchaser has received a copy of the audited
                        financial statements of the Company for the fiscal year
                        ended December 31, 2003 ("Audited Financial
                        Statements"), and the related statements of income and
                        retained earnings for the period then ended. The Audited
                        Financial Statements have been prepared in accordance
                        with generally accepted accounting principles
                        consistently followed by the Company throughout the
                        periods indicated. Such financial statements fairly
                        present the financial condition of the Company at the
                        dates indicated and its results of operations and

                                       6
<PAGE>

                        cash flows for the periods then ended and, except as
                        indicated therein, reflect all claims against, debts and
                        liabilities of the Company, fixed or contingent, and of
                        whatever nature.

                  (b)   Except as set forth on Schedule 3.7(b), since June 30,
                        2004 (the "Balance Sheet Date"), there has been no
                        material adverse change in the assets or liabilities, or
                        in the business or condition, financial or otherwise, or
                        in the results of operations or prospects, of the
                        Company, whether as a result of any legislative or
                        regulatory change, revocation of any license or rights
                        to do business, fire, explosion, accident, casualty,
                        labor trouble, flood, drought, riot, storm,
                        condemnation, act of God, public force or otherwise and
                        no material adverse change in the assets or liabilities,
                        or in the business or condition, financial or otherwise,
                        or in the results of operation or prospects, of the
                        Company except in the ordinary course of business.

                  (c)   Since the Balance Sheet Date, the Company has not
                        suffered any damage, destruction or loss of physical
                        property (whether or not covered by insurance) affecting
                        its condition (financial or otherwise) or operations
                        (present or prospective), nor has the Company issued,
                        sold or otherwise disposed of, or agreed to issue, sell
                        or otherwise dispose of, any capital stock or any other
                        security of the Company and has not granted or agreed to
                        grant any option, warrant or other right to subscribe
                        for or to purchase any capital stock or any other
                        security of the Company or has incurred or agreed to
                        incur any indebtedness for borrowed money.

            3.8 No Litigation. The Company is not a party to any suit, action,
arbitration, or legal, administrative, or other proceeding, or pending or
threatened governmental investigation. The Company is not subject to or in
default with respect to any order, writ, injunction, or decree of any federal,
state, local, or foreign court, department, agency, or instrumentality.

            3.9 No Taxes. The Company is not, and will not become with respect
to any periods ending on or prior to the Closing Date, liable for any income,
sales, withholding, franchise, excise, license, real or personal property taxes
(a "Tax") to any foreign, United States federal, state or local governmental
agencies whatsoever, including without limitation, in respect of the forgiveness
of debt to be made by the Seller on or prior to the Closing Date. All United
States federal, state, county, municipality local or foreign income Tax returns
and all other material Tax returns (including information returns) that are
required, or have been required, to be filed by or on behalf of the Company have
been or will be filed as of the Closing Date and all Taxes due pursuant to such
returns or pursuant to any assessment received by the Company have been or will
be paid as of the Closing Date. The charges, accruals and reserves on the books
of the Company in respect of taxes or other governmental charges have been
established in accordance with GAAP. All returns that have been filed or lodged
relating to Tax are true and accurate in all material respects. No audit,
action, suit, proceeding or other examination

                                       7
<PAGE>

regarding taxes for which the Company may have any liability is currently
pending against or with respect to the Company and neither Seller nor Company
has received any notice (formally or informally) of any audit, suit, proceeding
or other examination. No material adjustment relating to any Tax returns, no
closing or similar agreement has been entered into or issued or has been
proposed (formally or informally) by any tax authority (insofar as such action
relate to activities or income of or could result in liability of the Company
for any Tax) and no basis exists for any such action. The Company has not
changed any election, adopted or changed any accounting method or period, filed
any amended return for any Tax, settled any claim or assessment of any Tax, or
surrendered any right to claim any refund of any Tax, or consented to any
extension or waiver of the statute of limitations for any Tax. The Company has
not had an "ownership change" as that term is defined in Section 382 of the
Internal Revenue Code of 1986, as amended and in effect.

            3.10  Material Agreements.

                  (a)   Schedule 3.10(a) represents and contains a complete and
                        correct list of all material contracts entered into by
                        the Company other than those assumed by Aisle Seats,
                        Inc. pursuant to an asset purchase agreement between
                        Aisle Seats, Inc. and the Company of even date herewith,
                        including, but not limited to, all contracts, (a) which
                        have unexpired terms of more than one (1) year or cannot
                        be terminated by the Company without penalty or payment
                        on thirty (30) days notice or less; (b) which would
                        require over the full term thereof payments by the
                        Company of more than $5,000; or (c) pursuant to which
                        there were payments by or to the Company of more than
                        $5,000 for the calendar year ended December 31, 2003.
                        True and correct copies of the contracts listed on
                        Schedule 3.10(a) have been delivered or made available
                        to Purchaser. Each of such contracts is valid, binding
                        and enforceable against the Company and the other
                        parties thereto, in accordance with its terms, and to
                        the best knowledge of the Company is in full force and
                        effect. Except as set forth in Schedule 3.10(a), to the
                        best knowledge of the Company, each of the other parties
                        thereto has performed in all material respects all
                        obligations required to be performed by it under, and is
                        not in default in any material respect under, any of
                        such contracts, and no event has occurred which, with
                        notice or lapse of time, or both, would constitute such
                        a default. Except as disclosed on Schedule 3.10(a), the
                        Company has not received any written claim from any
                        other party to any such contract that the Company has
                        breached any obligations to be performed by it
                        thereunder, or is otherwise in default or delinquent in
                        performance thereunder. Except as disclosed on Schedule
                        3.10(a), there are no contracts to which the Company is
                        a party that contain provisions relating to agreements
                        not to compete that bind the Company which affect or
                        restrict the conduct of the business as currently
                        conducted or could reasonably be expected to affect or
                        restrict the conduct of the

                                       8
<PAGE>

                        business of the Company, as intended to be conducted by
                        Purchaser after the Closing.

                  (b)   Phyllis Maxwell has and upon consummation of the
                        transactions contemplated by this Agreement, Purchaser
                        will have good and marketable title to the Shares.

                  (c)   [Intentionally Deleted].

                  (d)   The Company owns no property and has a valid leasehold
                        interest in all properties occupied by it. Such leases
                        are set forth on Schedule 3.10(d).

                  (e)   Except as set forth on Schedule 3.10(e):

                        (i)   The Company does not have, and never has had, any
                              employees or agents.

                        (ii)  The Company has no employment contracts or
                              agreements with any of its officers, directors, or
                              with any consultants, employees or other such
                              parties.

                        (iii) The Company has no stockholder contracts or
                              agreements.

                  (f)   The Company has no outstanding powers of attorney and no
                        obligations concerning the performance of the Seller
                        concerning this Agreement.

                  (g)   The Company is not required to hold and does not hold
                        any Permits ("Permits" means all licenses, franchises,
                        grants, authorizations, permits, easements, variances,
                        exemptions, consents, certificates, orders and approvals
                        necessary to own, lease and operate the properties, of,
                        and to carry on the business of the Company).

                  (h)   Neither the Company nor, to the Company's knowledge, any
                        employee or agent of the Company has made any payments
                        of funds of the Company, or received or retained any
                        funds, in each case in violation of any law, rule or
                        regulation or of a character required to be disclosed by
                        the Company in any of the SEC Reports.

                  (i)   There are no outstanding judgments or UCC financing
                        statements or UCC security interests filed against the
                        Company or any of its properties.

                                       9
<PAGE>

                  (j)   The Company has no debt, loans, or obligations of any
                        kind, to any of its directors, officers, stockholders or
                        employees or third parties that will not be satisfied
                        prior to the Closing Date.

                  (k)   The Company has no outstanding provisions for
                        indemnification of any person with respect to
                        liabilities relating to any current or former business
                        of the Company or any predecessor person.

            3.11 No Liabilities. Except as set forth in the financial statements
of the Company and other than expenses arising in the ordinary course of
business consistent with past practices and related to this Agreement and
related transactions, and expenses incurred or accrued to prepare and file the
quarterly report of the Company on Form 10-QSB for the quarter ended June 30,
2004: (a) there are no liabilities of the Company of any kind whatsoever,
whether accrued, contingent, absolute, determined, determinable or otherwise,
and there is no existing condition, situation or set of circumstances that could
reasonably be expected to result in such a liability; and (b) except as set
forth on Schedule 3.11(b), the Company does not have any debt, liability, or
obligation of any nature, whether accrued, absolute, contingent, or otherwise,
and whether due or to become due, that is not reflected on the Company's
financial statements.

            3.12 OTC Listing. The Company is currently listed on the OTC
Electronic Bulletin Board under the trading symbol "CXTX."

            3.13 Compliance with Law. To the best of its knowledge, the Company
has complied with, and is not in violation of any provision of laws or
regulations of federal, state or local government authorities and agencies
applicable to its business. There are no pending or threatened proceedings
against the Company by any federal, state or local government, or any
department, board, agency or other body thereof.

            3.14 Corporate Documents Effective. The articles of incorporation,
as amended, and the bylaws of the Company, as provided to Purchaser and attached
at Exhibit 1, are in full force and effect and all actions of the Board of
Directors or stockholders required to accomplish same have been taken.

            3.15 No Stockholder Approval Required. The acquisition of the Shares
by Purchaser from Seller does not require the approval of the stockholders of
the Company under any applicable law, the Company's articles of incorporation or
bylaws, or any other requirement of law or, if stockholder approval is required
it has or will, prior to the Closing, be properly obtained in accordance with
the requirements of the Company's articles of incorporation and by-laws and
applicable law.

            3.16 No Dissenters' Rights. The acquisition of the Shares by
Purchaser from Seller will not give rise to any dissenting stockholders' rights
under applicable law, the Company's articles of incorporation or bylaws, or
otherwise.

            3.17 Not Subject to Voting Trust. None of the Shares are or will be
subject to any voting trust or agreement. No person holds or has the right to
receive any proxy or similar instrument with respect to such Shares. The Company
is not a party to any agreement that offers or grants to any person the right to
purchase or acquire any of the securities to be issued pursuant

                                       10
<PAGE>

to this Agreement. There is no applicable local, state or federal law, rule,
regulation, or decree which would, as a result of the transfer of the Shares to
Purchaser, impair, restrict or delay any voting rights with respect to the
Shares.

            3.18 Prior Offerings. All issuances by the Company of shares of
Common Stock in past transactions have been legally and validly effected, and
all of such shares of Common Stock are fully paid and non-assessable. All of the
offerings of the Company's Common Stock were conducted in accordance with the
requirements of Regulation D, Rules 504 and 506, as applicable, in compliance
with the requirements of the Securities Act of 1933 and in compliance with and
according to the requirements of applicable law and the Company's articles of
incorporation and bylaws.

            3.19 True Representations. The information heretofore furnished by
the Seller or the Company to the Purchaser for purposes of or in connection with
this Agreement or any transaction contemplated hereby does not, and all such
information hereafter furnished by the Seller or the Company to the Purchaser
will not (in each case taken together and on the date as of which such
information is furnished), contain any untrue statement of a material fact or
omit to state a material fact necessary in order to make the statements
contained therein, in the light of the circumstances under which they are made,
not misleading.

            3.20 Complete Books and Records. The Certificates and all corporate
records and documents of Company (which have been made available for inspection
by Purchaser prior to the date hereof) are true and complete in all respects.

            3.21 Corporate Name. The Company (i) has the exclusive right to use
the name "Clixtix, Inc." as the name of a corporation in any jurisdiction in
which the Company does business and (ii) has not received any notice of conflict
in the past with respect to the rights of others regarding the corporate name of
the Company. To the knowledge of the Seller, no person is presently authorized
by the Seller or the Company to use the name of the Company. Seller has
previously made available to Purchaser copies of any documents in the possession
of the Seller granting any authorizations of the type referred to in the
previous sentence.

            3.22 Complete Shareholder List. The list of shareholders of the
Company and their respective holdings of shares in the Company to be delivered
to the Purchaser at the Closing Date is complete, true, accurate and complete in
all respects as of the date such shareholder list was generated.

            3.23 Survival. The representations and warranties in this Article 3
will be true and correct in all material respects on and as of the Closing Date
with the same force and effect as though said representations and warranties had
been made on and as of the Closing Time and will survive the Closing Date for a
period of three (3) years, provided, however, that the representations and
warranties set out at Section 3.1 and 3.2 shall not be limited by this Section
3.23 and the representation and warranty set out at Section 3.9 shall survive
for all applicable statutes of limitations.

                                       11
<PAGE>

                                    ARTICLE 4
                   REPRESENTATIONS AND WARRANTIES OF PURCHASER

            Unless specifically stated otherwise, Purchaser represents and
warrants that the following are true and correct as of the date hereof and will
be true and correct through the Closing Date as if made on that date:

            4.1 Agreement's Validity. This Agreement has been duly executed and
delivered by Purchaser and constitutes a legal, valid and binding obligation of
Purchaser, enforceable against Purchaser in accordance with its terms, except as
may be limited by applicable bankruptcy, insolvency or similar laws affecting
creditors' rights generally or the availability of equitable remedies.

            4.2 Investment Intent. Purchaser is acquiring the Shares for its own
account for investment and not with a view to, or for sale or other disposition
in connection with, any distribution of all or any part thereof, except in an
offering covered by a registration statement filed with the Commission under the
Securities Act covering the Shares, or pursuant to an applicable exemption under
the Securities Act.

            4.3 Restricted Securities. Purchaser understands that the Shares
have not been registered pursuant to the Securities Act or any applicable state
securities laws, that the Shares will be characterized as "restricted
securities" under federal securities laws, and that under such laws and
applicable regulations the Shares cannot be sold or otherwise disposed of
without registration under the Securities Act or an exemption therefrom. In this
connection, Purchaser represents that it is familiar with Rule 144 promulgated
under the Securities Act, as currently in effect, and understands the resale
limitations imposed thereby and by the Securities Act. Stop transfer
instructions may be issued to the transfer agent for securities of the Company
(or a notation may be made in the appropriate records of the Company) in
connection with the Shares.

            4.4 Legend. It is agreed and understood by Purchaser that the
Certificates representing the Shares shall each conspicuously set forth on the
face or back thereof a legend in substantially the following form:

            THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
            OF 1933. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR
            HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT
            AS TO THE SECURITIES UNDER SAID ACT OR PURSUANT TO AN EXEMPTION FROM
            REGISTRATION OR AN OPINION OF COUNSEL SATISFACTORY TO THE COMPANY
            THAT SUCH REGISTRATION IS NOT REQUIRED.

            4.5 Disclosure of Information. Purchaser acknowledges that it has
been furnished with information regarding the Company and its business, assets,
results of operations, and financial condition to allow Purchaser to make an
informed decision regarding an investment in the Shares. Purchaser represents
that it has had an opportunity to ask questions of and receive answers from the
Company regarding the Company and its business, assets, results of operation,
and financial condition.

                                       12
<PAGE>

            4.6 Affirmation of No Solicitation. Purchaser affirms that he was
not solicited by Seller to enter into this Agreement.

                                    ARTICLE 5
                                 INDEMNIFICATION

            5.1 Seller shall be liable for and hereby agrees to indemnify and
hold harmless the Purchaser and the Company (which includes, for purposes of
this Article, Purchaser's and the Company's officers and directors, and
stockholders) against any Losses joint or several, to which Purchaser and/or the
Company may become subject under the Securities Act, the Securities Exchange
Act, any state or federal law, statutory or common law, or otherwise insofar as
such losses, claims, damages or liabilities (or actions or proceedings, whether
commenced or threatened, in respect thereof) that arise from, relate to or are
otherwise in respect of:

                  (a)   the inaccuracy of any warranty or representation of
                        Seller or Company contained in this Agreement, or any
                        omission or alleged omission to state therein a material
                        fact required to be stated therein or necessary to make
                        the statements therein not misleading;

                  (b)   any breach of any covenant of the Seller contained in
                        this Agreement; or

                  (c)   the Company or its assets or liabilities to the extent
                        that such Losses relate to events, occurrences, actions,
                        omissions, facts or circumstances occurring or existing
                        prior to the Closing Date, except for such liabilities
                        that are expressly retained by the Company.

This indemnification will include, without limitation whatsoever,
indemnification for all liabilities for Taxes of the Company or Taxes of the
Seller or any other corporation which is or has been affiliated with the Seller
(other than the Company) for all periods ending on or prior to the Closing Date
and all Taxes for the Company or Taxes of the Seller or any other corporation
which is or has been affiliated with the Seller (other than the Company) for all
periods ending on or prior to the Closing Date. Seller will in addition
reimburse Purchaser and the Company for any legal or any other expenses
reasonably incurred by Purchaser in connection with investigating or defending
any such loss, claim, liability, action or proceeding. The indemnity provided
for in this Section 5.1 shall remain in full force and effect regardless of any
investigations made by or on behalf of Purchaser and shall survive the Closing
for a period of two years, and with respect to any Tax, for the duration of any
applicable statute of limitations. As used in this Section 5.1, "Losses" means
any loss, claim, demand, damage, award, liabilities, suits, penalties,
forfeitures, cost or expense (including, without limitation, reasonable
attorneys', consultant and other professional fees and disbursements of every
kind, nature and description).

            5.2 The Seller shall release all currently existing, new, or
hereinafter arising claims against the Company that relate to or in connection
with the execution of this Agreement and the performance of the transactions
contemplated herein.

                                       13
<PAGE>

            5.3 Purchaser shall be liable for and hereby agrees to indemnify and
hold harmless Seller against any Losses joint or several, to which Seller may
become subject under the Securities Act, the Securities Exchange Act, any state
or federal law, statutory or common law, or otherwise insofar as such losses,
claims, damages or liabilities (or actions or proceedings, whether commenced or
threatened, in respect thereof) that arise from, relate to or are otherwise in
respect of:

                  (a)   the inaccuracy of any warranty or representation of
                        Purchaser contained in this Agreement;

                  (b)   any breach of any covenant of the Purchaser contained in
                        this Agreement; or

                  (c)   the Company or its assets or liabilities to the extent
                        that such Losses relate to events, occurrences, actions,
                        omissions, facts or circumstances that occur after the
                        Closing Date.

            Purchaser will in addition reimburse Seller for any legal or any
other expenses reasonably incurred by Seller in connection with investigating or
defending any such loss, claim, liability, action or proceeding. The indemnity
provided for in this Section 5.3 shall remain in full force and effect
regardless of any investigations made by or on behalf of Seller and shall
survive the Closing for a period of two years. As used in this Section 5.3,
"Losses" means any loss, claim, demand, damage, award, liabilities, suits,
penalties, forfeitures, cost or expense (including, without limitation,
reasonable attorneys', consultant and other professional fees and disbursements
of every kind, nature and description).

            5.4 All indemnification payments required to be made under this
Agreement shall be made on an after-Tax basis, meaning that any such payment
shall be increased to account for the imposition of any Tax resulting from the
receipt or accrual of such indemnity payment, such that the net amount received
by the indemnified party or parties is equal to the full amount of the payment
prior to the imposition of and adjustment for such Taxes.

                                    ARTICLE 6
            CLOSING, DELIVERY OF DOCUMENTS AND POST CLOSING COVENANTS

            6.1 Closing. The Closing Date shall be held on or before September
13, 2004. The Closing Date shall occur as a single integrated transaction, as
follows.

                  (a)   Delivery by Seller. Seller shall deliver to Purchaser:

                        (i)   an executed copy of the release (in a form
                              reasonably satisfactory to the Purchaser) of all
                              debt obligations of the Company owed to the
                              Seller;

                        (ii)  copies of board resolutions by the Board of
                              Directors of the Company approving the terms of
                              this Agreement and the execution of the Agreement
                              by the Company.

                                       14
<PAGE>

                        (iii) copies of all books, records and documents
                              relating to the Company;

                        (iv)  a letter signed by the Seller (in a form
                              reasonably satisfactory to the Purchaser)
                              confirming that the Shares are the sole management
                              community property of the Seller;

                        (v)   a certified copy of the list of the Company's
                              shareholders and their respective holdings of
                              shares in the Company as of the Closing Date;

                        (vi)  any other such instruments, documents and
                              certificates as are required to be delivered by
                              Seller or its representatives pursuant to the
                              provisions of this Agreement; and

                        (vii) the Certificates to Purchaser as directed by
                              Purchaser.

                  (b)   Delivery by Purchaser:

                        (i)   The Purchaser shall pay to the Seller the Purchase
                              Price of $248,245 in U.S. currency by wire
                              transfer to a bank account designated in writing
                              by the Seller or by delivery of a certified check.

                  (c)   Post-Closing Actions:

                        (i)   Immediately upon the Closing Date, the Board of
                              Directors of the Company shall resolve to appoint
                              Jack Kachkar as a director of the Company with
                              immediate effect; and

                        (ii)  Following the appointment of Jack Kachkar to the
                              Board of Directors of the Company, the Seller
                              shall resign from the Board of Directors.

            6.2 Related Transactions. As a condition to each party's performance
pursuant to Section 6.1, the agreements governing the Related Transactions shall
have been executed and subsequently consummated.

                                    ARTICLE 7
                              AMENDMENT AND WAIVER

            7.1 Waiver. Any term, provision, covenant, representation, warranty
or condition of this Agreement may be waived, but only by a written instrument
signed by the party entitled to the benefits thereof. The failure or delay of
any party at any time or times to require performance of any provision hereof or
to exercise its rights with respect to any provision hereof shall in no manner
operate as a waiver of or affect such party's right at a later time to enforce
the same. No waiver by any party of any condition, or of the breach of any term,
provision, covenant, representation or warranty contained in this Agreement, in
any one or more instances,

                                       15
<PAGE>

shall be deemed to be or construed as a further or continuing waiver of any such
condition or breach or waiver of any other condition of the breach of any other
term, provision, covenant, representation or warranty. No modification or
amendment of this Agreement shall be valid and binding unless it be in writing
and signed by all parties hereto.

                                    ARTICLE 8
                             POST CLOSING COVENANTS

            8.1 Immediately following the Closing hereunder, all of the capital
stock of Medeorex, Inc. shall be transferred and assigned to the Company (the
"Medeorex Transaction") on the terms and conditions set forth in that certain
Share Exchange Agreement in the form attached hereto as Exhibit A.

            8.2 Immediately following the closing of the Medeorex Transaction,
all of the assets of the Company shall be transferred and assigned to an entity
controlled by Seller on the terms and conditions set forth in that certain Asset
Purchase Agreement in the form attached hereto as Exhibit B.

                                    ARTICLE 9
                                  MISCELLANEOUS

            9.1 Entire Agreement. This Agreement sets forth the entire agreement
and understanding of the parties hereto with respect to the transactions
contemplated hereby, and supersedes all prior agreements, arrangements and
understanding related to the subject matter hereof. No understanding, promise,
inducement, statement of intention, representation, warranty, covenant or
condition, written or oral, express or implied, whether by statute or otherwise,
has been made by any party hereto which is not embodied in this Agreement or the
written statement, certificates, or other documents delivered pursuant hereto or
in connection with the transactions contemplated hereby, and no party hereto
shall be bound by or liable for any alleged understanding, promise, inducement,
statement, representation, warranty, covenant or condition not set forth.

            9.2 Notices. Any notice or communications hereunder must be in
writing and given by depositing same in the United States mail addressed to the
party to be notified, postage prepaid and registered or certified mail with
return receipt requested or by delivering same in person. Such notices shall be
deemed to have been received on the date on which it is hand delivered or on the
third business day following the date on which it is to be mailed. For purpose
of giving notice, the addresses of the parties shall be:

                   If to Seller:

                            Phyllis Maxwell
                            Suite 1807-1501 Broadway
                            New York, NY 10036
                            Fax:  212-768-3036

                                       16
<PAGE>

                   If to Purchaser to:

                            First Jemini Trust
                            c/o Trustee
                            76 Sanibel Crescent
                            Thornhill Ontario, Canada L4J 8K7
                            Fax:  (905) 771-9636

                   If to Company to:

                            Clixtix, Inc.
                            Suite 1807-1501 Broadway
                            New York, NY 10036
                            Fax:  212-768-3036

            9.3 Governing Law. This Agreement shall be governed in all respects,
including validity, construction, interpretation and effect, by the laws of the
State of New York (without regard to principles of conflicts of law).

            9.4 Consent to Jurisdiction. Each party irrevocably submits to the
exclusive jurisdiction of the appropriate state or federal court in the state of
New York for the purposes of any suit, action or other proceeding arising out of
this Agreement or any transaction contemplated hereby or thereby. Each party
agrees to commence any such action, suit or proceeding in a United States
District Court for the Southern District of New York, or if such suit, action or
other proceeding may not be brought in such court for jurisdictional reasons, in
the Southern court of New York. The parties agree that any service of process to
be made hereunder may be made by certified mail, return receipt requested,
addressed to the party at the address appearing in Section 9.2, together with a
copy to be delivered to such party's attorneys via telecopier (if provided in
Section 9.2). Such service shall be deemed to be completed when mailed and sent
and received by Telecopier. Seller and Purchaser each waive any objection based
on forum non-conveniens. Nothing in this paragraph shall affect the right of
Seller or Purchaser to serve legal process in any other manner permitted by law.

            9.5 Counterparts. This Agreement may be executed by the parties
hereto in separate counterparts each of which shall be deemed an original, but
all of which together shall constitute one and the same instrument.

            9.6 Waivers and Amendments; Non-Contractual Remedies; Preservation
of Remedies. This Agreement may be amended, superseded, canceled, renewed, or
extended, and the terms hereof may be waived, only by a written instrument
signed by authorized representatives of the parties or, in the case of a waiver,
by an authorized representative of the party waiving compliance. No such written
instrument shall be effective unless it expressly recites that it is intended to
amend, supersede, cancel, renew or extend this Agreement or to waive compliance
with one or more of the terms hereof, as the case may be. No delay on the part
of any party in exercising any right, power or privilege hereunder shall operate
as a waiver thereof, nor shall any waiver on the part of any party of any such
right, power or privilege, or any single or partial exercise of any such right,
power of privilege, preclude any further exercise

                                       17
<PAGE>

thereof or the exercise of any other right, power or privilege. The rights and
remedies herein provided are cumulative and are not exclusive of any rights or
remedies that any party may otherwise have at law or in equity. The rights and
remedies of any party based upon, arising out of or otherwise in respect of any
inaccuracy in or breach of any representation, warranty, covenant or agreement
contained in this Agreement shall in no way be limited by the fact that the act,
omission, occurrence or other state of facts upon which any claim of any such
inaccuracy or breach is based may also be the subject of any other
representation, warranty, covenant or agreement contained in this Agreement (or
in any other agreement between the parties) as to which there is no inaccuracy
or breach.

            9.7 Binding Effect; No Assignment, No Third-Party Rights. This
Agreement shall be binding upon and inure to the benefit of the parties and
their respective successors and permitted assigns. This Agreement is not
assignable without the prior written consent of each of the parties hereto or by
operation of law. This Agreement is for the sole benefit of the parties hereto
and their permitted assigns, and nothing herein, expressed or implied, shall
give or be construed to give to any person, including any union or any employee
or former employee of Seller, any legal or equitable rights, benefits or
remedies of any nature whatsoever, including any rights of employment for any
specified period, under or by reason of this Agreement.

            9.8 Further Assurances. Each party shall, at the request of the
other party, at any time and from time to time following the Closing Date
promptly execute and deliver, or cause to be executed and delivered, to such
requesting party all such further instruments and take all such further action
as may be reasonably necessary or appropriate to carry out the provisions and
intents of this Agreement and of the instruments delivered pursuant to this
Agreement.

            9.9 Severability of Provisions. If any provision or any portion of
any provision of this Agreement or the application of any such provision or any
portion thereof to any person or circumstance, shall be held invalid or
unenforceable, the remaining portion of such provision and the remaining
provisions of the Agreement, or the application of such provision or portion of
such provision is held invalid or unenforceable to person or circumstances other
than those as to which it is held invalid or unenforceable, shall not be
affected thereby and such provision or portion of any provision as shall have
been held invalid or unenforceable shall be deemed limited or modified to the
extent necessary to make it valid and enforceable, in no event shall this
Agreement be rendered void or unenforceable.

            9.10 Exhibits and Schedules. All exhibits annexed hereto, and all
schedules referred to herein, are hereby incorporated in and made a part of this
Agreement as if set forth herein. Any matter disclosed on any schedule referred
to herein shall be deemed also to have been disclosed on any other applicable
schedule referred to herein.

            9.11 Captions. All section titles or captions contained in this
Agreement or in any schedule or exhibit annexed hereto or referred to herein,
and the table of contents to this Agreement, are for convenience only, shall not
be deemed a part of this Agreement and shall not affect the meaning or
interpretation of this Agreement. All references herein to sections shall be
deemed references to such parts of this Agreement, unless the context shall
otherwise require

                                       18
<PAGE>

            9.12 Expenses. Except as otherwise expressly provided in this
Agreement, whether or not the Closing Date occurs, each party hereto shall pay
its own expenses incidental to the preparation of this Agreement, the carrying
out of the provisions hereof and the consummation of the transactions
contemplated. For the avoidance of doubt, any fees and expenses incurred by the
Seller or the Company in connection with entering into this Agreement and the
transactions contemplated hereby shall be paid by the Seller and not the
Company.

            9.13 Public Announcements. The parties agree to consult with each
other before issuing any press release or making any public statement or
completing any public filing with respect to this Agreement or the transactions
contemplated hereby and, except as may be required by applicable law or any
listing agreement with any national securities exchange or quotation system,
will not issue any such press release or make any such public statement prior to
consultation.

            9.14 Non-confidentiality. Notwithstanding Section 9.13, the Company,
Seller and Purchaser, and each employee, representative or other agent of the
same (collectively the "Covered Parties"), may disclose to any and all persons,
without limitation of any kind, the tax treatment and tax structure of the
transaction and all materials of any kind (including opinions or other tax
analyses) that are provided to a Covered Party relating to such tax treatment
and tax structure.

                            [Signature Page Follows]

                                       19
<PAGE>

            IN WITNESS WHEREOF, the parties hereto have executed this Agreement,
as of the date first written herein above.

                                        By:      /s/ Phyllis Maxwell
                                           ------------------------------
                                                 Phyllis Maxwell

                                        FIRST JEMINI TRUST

                                        By:      /s/ Larry Stockhamer
                                           ------------------------------
                                                 Larry Stockhamer
                                                 Trustee

                                        CLIXTIX, INC.

                                        By:      /s/ Phyllis Maxwell
                                           ------------------------------
                                                 Phyllis Maxwell
                                                 PresidentADHEREX STOCK OPTION PLAN

 EXHIBIT 4.1 
  

ADHEREX TECHNOLOGIES INC. 
 STOCK
OPTION PLAN 
  
 PLAN DESCRIPTION 
  

	1.	Purpose of the Plan 

  
 The purpose of the Stock Option Plan is to develop the interest and incentive of eligible employees, directors and other service providers of ADHEREX TECHNOLOGIES INC. (the “Company”) in the Company’s
growth and development by giving eligible employees, directors and other service providers an opportunity to purchase Common Shares on a favourable basis, thereby advancing the interests of the Company, enhancing the value of the Common Shares for
the benefit of all the shareholders and increasing the ability of the Company to attract and retain skilled and motivated individuals in the service of the Company. 
  
 The Board of Directors has approved the terms of this Plan. 
  

	2.	Definitions 

  
 In this Plan: 
  

	(a)	“Board of Directors” means the board of directors of the Company; 

  

	(b)	“Committee” means the appropriate compensation committee appointed by the Board of Directors to administer the Plan. All references in the Plan to the Committee
means the Board of Directors if no Committee has been appointed; 

  

	(c)	“Common Shares” means the Common Shares of the Company or, in the event of an adjustment contemplated in Section 9 hereof, such other Common Shares to which a
Participant may be entitled upon the exercise of an Option as a result of such adjustment; 

  

	(d)	“Date of Grant” means the date a Participant is granted an Option to purchase Option Shares; 

  

	(e)	“Director” means a person occupying the position of director on the Board of Directors; 

  

	(f)	“Employee” means a full time permanent employee of the Company or its subsidiaries; 

  

	(g)	“Exchange” means The Toronto Stock Exchange or, if the Common Shares are not then listed and posted for trading on The Toronto Stock Exchange, on such stock
exchange or quotation system on which such shares are listed, posted for trading or quoted as may be selected by the Committee; 

  

	(h)	“Exercise Date” means the date the Company receives from the Participant a completed Stock Option Purchase Form with payment for the Option Shares being purchased;

  

	(i)	“Fair Market Value” at any date in respect of the Common Shares shall be determined by the Committee in its sole discretion, unless the Common Shares become listed
and posted for trading on the Exchange, in which case the Fair Market Value shall be equal to the closing price of the Common Shares on the Exchange on the trading day immediately preceding the Date of Grant; 

	(j)	“Option” means an option to purchase Common Shares from the treasury of the Company granted to a Participant; 

  

	(k)	“Option Price” means the price per share at which a Participant may purchase Option Shares; 

  

	(l)	“Option Shares” means the Common Shares of the Company which a Participant is entitled to purchase under the Plan; 

	

	(m)	“Participants” means Directors, Employees and Service Providers to whom Option Shares are granted pursuant to the Plan and which remain unexercised;

  

	(n)	“Plan” means the Adherex Technologies Inc. Stock Option Plan, as the same may be amended and restated from time to time; 

  

	(o)	“Service Provider” means any person other than an Employee or Director, engaged to provide ongoing management, advisory or consulting services for the Company or
for a subsidiary of the Company; 

  

	(p)	“Stock Option Agreement” means the stock option agreement to be entered into between the Company and a Participant of the Plan upon the grant of an Option to a
Participant in the form of Appendix “A”; and 

  

	(q)	“Vesting Period” means the period(s) as stipulated herein or in the Stock Option Agreement that the Participant may purchase the Option Shares.

  

	3.	Eligibility and Number of Option Shares Subject to Plan 

  
 Participation in the Plan shall be limited to Participants who are designated from time to time by the Committee. Participation shall be voluntary and the extent to which
any Participant shall be entitled to participate in the Plan shall be determined by the Committee. Until changed in accordance with Section 16, the maximum number of Option Shares issuable under this Plan shall be 20,000,000 Common Shares, subject
to adjustment in accordance with Section 8. 
  
 Notwithstanding the foregoing, so
long as the Common Shares are listed and posted for trading on the Exchange, the number of Common Shares reserved for issuance pursuant to options to any one (1) person shall not exceed 5% of the issued and outstanding Common Shares at such time.

  
 No fractional shares may be purchased or issued hereunder. Subject to the
foregoing, the number of Option Shares that a Participant is entitled to purchase under the Plan will be determined by the Committee. 
  
 4. Price for Option Shares 
  
 The Committee shall advise each Participant designated to participate in the Plan of the number of Option Shares such Participant is entitled to purchase and the Option
Price at which the Option Shares may be purchased and the Vesting Period. The Option Price at which the Option Shares may be purchased under the Plan shall be fixed by the Committee based upon the Fair Market Value of the Common Shares of the
Company. The Committee may impose performance thresholds which will need to be met prior to vesting of any Options granted. 

	5.	Exercise 

  
 Options granted under the Plan must be exercised within a period of seven (7) years from the Date of Grant, failing which the Participant’s right to purchase such Option Shares lapses. Unless otherwise determined
by the Committee and specifically set forth in the Stock Option Agreement to be executed by the Participant, the Vesting Periods within the seven (7) year term during which Options or a portion thereof vest and may be exercised by the Participant
shall be as follows: 
  
 one-third of the Option may be exercised
after the first anniversary of the date of grant; 
 one-third of the Option may be exercised after the second anniversary of the date of
grant; and 
 one-third of the Option may be exercised after the third anniversary of the date of grant. 
  
 Notwithstanding such vesting period or that certain vesting period set forth in the Stock
Option Agreement, the Committee may, in its sole discretion, by written notice to any Participant, accelerate the vesting of all or any of the Options such that the Options become immediately fully vested. In such circumstances, the Committee may by
written notice compel the Participant to exercise the Options within 30 days of the date of such written notice to exercise, failing which the Participant’s right to purchase such Option Shares lapses. 
  
 The Committee in its discretion may require that the exercise of an Option shall be subject
to the Option holder signing a counterpart of the then existing shareholders agreement of the Company or any other agreement which is to apply to Option holders. 
  

	6.	Payment 

  
 The Participant from time to time and at any time after the vesting of any Options and prior to the lapse of such Options, may elect to purchase all or a portion of the Option Shares available for purchase by lump sum
payment by delivering to the Company at its registered office, a completed stock option purchase form in the form attached hereto as Appendix “A”. Payment may be made by cash, certified cheque, bank draft or money order payable to the
order of Adherex Technologies Inc. 
  

	7.	Share Certificates 

  
 Upon exercise of the Option and payment in full of the purchase price the Company shall cause to be delivered to the Participant within a reasonable period of time a duplicate certificate or certificates in the name
of the Participant representing the number of Option Shares the Participant has purchased. The original share certificate shall be held in trust by the Company for delivery to the holder when the shares are to be transferred, as authorized by the
Plan. 
  

	8.	Adjustment in Shares 

  
 Appropriate adjustments in the number of Common Shares subject to the Plan and, as regards Options granted or to be granted, in the number of Common Shares optioned and in the Option Price, shall be made by the
Committee to give effect to the adjustments in the number of Common Shares resulting from sub-divisions, consolidations or re-classification of the Common Shares or other relevant changes in the authorized or issued capital of the Company.

  
 In the event that the Company proposes to amalgamate, merge or consolidate
with any other corporation, other than a corporation not dealing at arm’s length with the Company as defined in the Income Tax Act (Canada) or a corporation which owns shares in the Company as at the date of the Plan, or to liquidate,
dissolve or wind-up, the Company shall give written notice thereof to each Participant holding Options under the Plan and such 

 Participants shall be entitled to exercise all or a portion of the Options granted to such Participants, whether or not
such Options have previously vested, within the 30 days period next following the giving of such notice. To the extent the proposed amalgamation, merger or consolidation is not completed in a reasonable time, the Company may purchase at the Option
Price the Option Shares acquired by the Participant pursuant to Options which would not have vested but for the acceleration of the Vesting Period. Upon the expiration of such 30 day period, all rights of the Participants to the Option Shares or to
the exercise of the Options shall terminate and cease to have any further force and effect. 
  

	9.	Termination Of Participant For Any Reason 

  

	(a)	In the event that an Employee’s employment with the Company or any of its subsidiaries is terminated for any reason, a Director shall cease to be a Director on the Board of
Directors for any reason or a Service Provider ceases to provide services to the Company, the Participant or the Participant’s legal representative, as the case may be, may elect to purchase at the Option Price all or a portion of the remaining
Option Shares (subject to Options that have vested at the time such employment, position on the Board of Directors or services with the Company is terminated) at any time during the 30 day period following the date of such termination of employment
or position on the Board of Directors or termination of services of a Service Provider (the “Participant Termination Date”), or if specifically approved by the Board of Directors at any time prior to the earlier of (x) the expiry date
thereof, or (y) the date that is three (3) years following the Participant Termination Date; and, to the extent the Company’s Common Shares are not listed on any Exchange, the Company may elect to purchase at the same Option Price paid by the
Participant or the Participant’s legal representative all of the Common Shares purchased by such Participant under this Plan. For the purposes of this Plan, the transfer of the Employee’s employment to the Company or to any subsidiary of
the Company shall not be considered a termination of employment and the Employee’s rights under the Option shall be the same as if such transfer had not occurred. 

  

	(b)	In the event of an offer by a third party to purchase all the shares of the Company, which offer shall be accepted by shareholders who collectively own shares representing 51% or
more of all of the voting shares of Company, the Participant irrevocably agrees that any shares owned by him/her at the time of such offer shall be tendered for sale in accordance with the terms of such offer. 

  

	10.	Transfer and Assignment 

  
 The Participant’s rights under Options granted under the Plan are not assignable or transferable by the Participant or subject to any other alienation, sale, pledge
or encumbrance by such Participant during the Participant’s lifetime and therefore the Options are exercisable during the Participant’s lifetime only by the Participant. The obligations of each Participant shall be binding on his or her
heirs, executors and administrators. 
  

	11.	Employment and Board of Directors Position Non-Contractual 

  
 The granting of an Option to a Participant under the Plan does not confer upon the Participant any right to continue in the employment of the Company or any subsidiary of
the Company or as a member of the Board of Directors or as a Service Provider, as the case may be, nor does it interfere in any way with the rights of the Employee or of the Company’s rights to terminate the Employee’s employment at any
time or of the shareholders’ right to elect Directors. 

	12.	Rights As Shareholders 

  
 Participants shall not have any rights as a shareholder with respect to Option Shares until full payment has been made to the Company and a share certificate or share
certificates have been duly issued. 
  

	13.	Administration Of The Plan 

  
 The Plan shall be administered by the Committee. The Committee shall have the power to interpret and construe the terms and conditions of the Plan and the Options. Any
determination by the Committee shall be final and conclusive on all persons affected thereby unless otherwise determined by the Board of Directors. The day-to-day administration of the Plan may be delegated to such officers and employees of the
Company or any subsidiary of the Company as the Committee shall determine. 
  

	14.	Notices 

  
 All written notices to be given by the Participant to the Company may be delivered personally or by registered mail, postage prepaid, addressed as follows: 
  
 Adherex Technologies Inc. 
 220-600 Peter Morand Cres. 
 Ottawa, Ontario K1G 5Z3 
 Attention:             Corporate Secretary 
  
 Any notice given by the Participant pursuant to the terms of the Option shall not be
effective until actually received by the Company at the above address. Any notice to be given to the Participant shall be sufficiently given if delivered personally or by postage prepaid mail to the last address of the Participant on the records of
the Company and shall be effective seven days after mailing. 
  

	15.	Corporate Action 

  
 Nothing contained in the Plan or in the Option shall be construed so as to prevent the Company or any subsidiary of the Company from taking corporate action which is deemed by the Company or the subsidiary to be
appropriate or in its best interest, whether or not such action would have an adverse effect on the Plan. 
  

	16.	Amendments 

  
 The Board of Directors of the Company shall have the right, in its sole discretion, to alter, amend or discontinue the Plan from time to time and at any time. No such amendment or discontinuation, however, may,
without the consent of the Participant, alter or impair his rights or increase his obligations under the Plan. Any amendment to the Plan or existing options is subject to the prior approval of the Exchange and may require the approval of the
Company’s shareholders. 
  

	17.	Governing Law 

  
 The Plan is established under the laws of the Province of Ontario and the rights of all parties and the construction and effect of each provision of the Plan shall be according to the laws of the Province of Ontario
and the laws of Canada applicable therein. 

	18.	Government Regulation 

  
 The Company’s obligation to issue and deliver Common Shares under any Option is subject to: 
  

	(a)	the satisfaction of all requirements under applicable securities law in respect thereof and obtaining all regulatory approvals as the Company shall determine to be necessary or
advisable in connection with the authorization, issuance or sale thereof, including shareholder approval, if required; 

  

	(b)	the admission of such Common Shares to listing on any stock exchange on which Common Shares may then be listed; and 

  

	(c)	the receipt from the Participant of such representations, agreements and undertakings as to future dealings in such Common Shares as the Company determines to be necessary or
advisable in order to safeguard against the violation of the securities law of any jurisdiction. 

  
 In this connection, the Company shall take all reasonable steps to obtain such approvals and registrations as may be necessary for the issuance of such Common Shares in compliance with applicable securities law and
for the listing of such Common Shares on any stock exchange on which such Common Shares are then listed. 

 Appendix “A” 
 Adherex Technologies Inc. 
  
 Stock Option Plan 
  
 Stock Option Agreement

  
 Date:
                     
  
 Dear                     : 
  
 This is to advise you that you have been granted an option (the “option”) to
purchase                      Common Shares at a price of $             per
share under the Adherex Technologies Inc. Stock Option Plan (the “plan”). 
  
 This option expires on the later of seven years following the date of grant, which appears on the right hand corner of this Notice, subject to other conditions of the Plan. 
  
 Subject to such expiry and the other provisions of the Plan, this option is exercisable in such amounts and at any time on or after:

  
                      shares on
                    , 200  . 
  
 This option is subject to the terms of the Plan. 
  
 Please refer to the Plan explanatory document for any additional information regarding the exercise of your option and completion of the Option Exercise Form. Please
execute a copy of this grant where indicated below and deliver it to the Corporate Secretary of the Company c/o Adherex Technologies Inc., 220-600 Peter Morand Crescent, Ottawa, Ontario K1G 5Z3, to acknowledge your acceptance of the terms hereof.

  
 Sincerely, 
 ADHEREX TECHNOLOGIES INC. 
  
 Per:
                             
  
 I have read, understood and accept the vesting provisions above and each of the terms and conditions described in a document called Adherex
Technologies Inc. Stock Option Plan and accept the foregoing grant of options on such basis. 
  
 Dated the      day of                     ,
            . 
  
  

	
	

	Signature

 Appendix “B” 
 Adherex Technologies Inc. 
  
 Stock Option Plan 
  
 Option Exercise Form

  
 Part 1: Identification 
  
  

			
	
	 	

	 Name of Participant
	 	Service
	
	 	  

	 Address
	 	 Office Telephone Number

	
	 	  

	 Social Insurance Number
	 	 Home Telephone Number

  
 Part 2: Option 
  
 I hereby exercise the Option granted to me by letter dated
                    under the Plan. 
  
 Total number of option stock exercised:                     

  

					
	 Method of payment:
	 	(a)	 	 Cash

	 	 	(b)	 	 Certified Cheque

	 	 	(c)	 	 Bank Draft

	 	 	(d)	 	 Money Order

  

			
	 Amount:
	 	  

	 Number of shares:
                (value:                )

  
 I hereby acknowledge that I have
read, understood and accepted each and all the terms and conditions described in a document called “Adherex Technologies Inc. Stock Option Plan”. 
  
 Given at                     , this,
             day of                      
  

	
	

	 Signature

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00071-of-00352.parquet"}]]